A $12 Billion Takeover Says That Gene Therapy Cancer Cures Are Big Business – MIT Technology Review
|
A $12 Billion Takeover Says That Gene Therapy Cancer Cures Are Big Business
MIT Technology Review Pharmaceutical firm Gilead Sciences has just put up a cool $11.9 billion to acquire Kite Pharma, which has developed a genetic engineering approach for treating cancers. The investment is a clear sign that gene therapy applied to cancer is a powerful … |
